| 摘要 |
<p>A method for the prophylaxis or direct treatment of mast cell implicated diseases or injuries in a patient which comprises administering to the site of the disease or injury an effective amount of at least one serine protease inhibitor, its salts, derivatives or analogs which bind with the mediators of mast cells or T-cells.</p> |
